These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6129672)

  • 1. Classical and non-classical neuroleptics induce supersensitivity of nigral GABA-ergic mechanisms in the rat.
    Coward DM
    Psychopharmacology (Berl); 1982; 78(2):180-4. PubMed ID: 6129672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam.
    Coward DM
    Psychopharmacology (Berl); 1982; 76(3):294-8. PubMed ID: 6808554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of nigral kainic acid-induced ipsilateral circling behaviour in the rat by neuroleptics and by contralateral caudate ablation.
    Coward DM
    Psychopharmacology (Berl); 1984; 84(4):526-30. PubMed ID: 6152056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat.
    Depaulis A; Vergnes M; Liu Z; Kempf E; Marescaux C
    Neuroscience; 1990; 39(2):339-49. PubMed ID: 2128373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circling behavior induced by intranigral injections of GABA and muscimol in rats.
    Kaakkola S; Kääriäinen I
    Psychopharmacology (Berl); 1980; 68(1):31-6. PubMed ID: 6771796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R; Guerin JJ; Davis KL
    Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters.
    Arnt J; Scheel-Krüger J
    Psychopharmacology (Berl); 1979 Apr; 62(3):267-77. PubMed ID: 37544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nigral NFkappaB p50 and p65 subunit expression in haloperidol-induced neurotoxicity and stereotyped behavior in rats.
    Saldaña M; Bonastre M; Aguilar E; Marin C
    Eur Neuropsychopharmacol; 2006 Oct; 16(7):491-7. PubMed ID: 16500086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The striatonigral GABA pathway: functional and neurochemical characteristics in rats with unilateral striatal kainic acid lesions.
    Waddington JL; Cross AJ
    Eur J Pharmacol; 1980 Oct; 67(1):27-32. PubMed ID: 6252027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential nigral expression of Bcl-2 protein family in chronically haloperidol and clozapine-treated rats: role in neurotoxicity and stereotyped behavior.
    Saldaña M; Bonastre M; Aguilar E; Marin C
    Exp Neurol; 2007 Feb; 203(2):302-8. PubMed ID: 17069804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of chronic treatment with chlorpromazine versus cocaine on behavioral responsiveness to nigral GABA receptor stimulation.
    Bachus SE; Gale K
    Psychopharmacology (Berl); 1988; 95(1):56-62. PubMed ID: 2838860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior modifications induced by unilateral administration of picrotoxin into rat substantia nigra].
    Boulu R; Lebas M; Ngoma-Yengo P
    C R Acad Hebd Seances Acad Sci D; 1977 Dec; 285(16):1549-52. PubMed ID: 417832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic haloperidol administration on GABA receptor binding.
    Huffman RD; Ticku MK
    Pharmacol Biochem Behav; 1983 Aug; 19(2):199-204. PubMed ID: 6314387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
    Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
    Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that the nigrotegmental GABAergic projection mediates stereotypy induced by apomorphine and intranigral muscimol.
    Childs JA; Gale K
    Life Sci; 1983 Sep; 33(10):1007-10. PubMed ID: 6684199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiochemical changes in tardive dyskinesia.
    Gunne LM; Häggström JE; Johansson P; Levin ED; Terenius L
    Encephale; 1988 Sep; 14 Spec No():167-73. PubMed ID: 2463901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of chronic haloperidol and sulpiride treatment on nigral and striatal GABA content.
    Nicoletti F; Patti F; Condorelli DF; Rampello L; Giammona G; Di Giorgio RM; Canonico PL; Scapagnini U
    J Neurochem; 1981 Oct; 37(4):1048-51. PubMed ID: 7320718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotational behaviour and striatal dopamine metabolism following unilateral activation of nigral GABA mechanisms: GABA-like modulation of dopaminergic and non-dopaminergic neurons in rat substantia nigra [proceedings].
    Waddington JL
    Br J Pharmacol; 1978 Jun; 63(2):384P. PubMed ID: 566600
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.